Skip to main content
. 2016 Dec 15;2016(12):CD011160. doi: 10.1002/14651858.CD011160.pub2

Comparison 5. Ranibizumab versus bevacizumab.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Change in visual acuity at 1 year 2 80 Mean Difference (IV, Fixed, 95% CI) ‐0.02 [‐0.11, 0.06]
2 Gain 3+ lines of visual acuity at 1 year 2 80 Risk Ratio (M‐H, Fixed, 95% CI) 0.79 [0.50, 1.27]
3 Choroidal neovascularisation angiographic closure at 1 year 2 80 Risk Ratio (M‐H, Fixed, 95% CI) 1.08 [0.95, 1.22]